Dr. Mohamed Osman El-Khosht, President of Cairo University, issued a decision to support the research teams formed at the university to develop a vaccine to treat the novel Coronavirus.
The university has allotted EGP 10 million, in order to continue the research efforts and provide their necessary needs to complete the ongoing scientific research.
Dr. El-Khosht said that the research teams at Cairo University, which comprises 25 researchers and scientists, include a number of professors of Faculties of Science, Medicine, and Pharmacy and the National Institute of Oncology.
These teams are carrying out their research work inside the university's laboratories to find a treatment for the Coronavirus.
He stressed that the current stage requires the efforts of all researchers and scientists because as the scientific research is the only way to surmount the current dire situation to confront the Coronavirus.
Dr. El-Khosht made clear that Cairo University pays great attention to scientific research in all fields during the past period, especially applied research as the university's strategy is based on scientific research to serve the public benefit and not researches authored for publishing in international scientific only.
He went on to say that the largest role of scientific research came to save humanity and not public benefit only. So that scientific research tops the good deeds, but rather the ones of it now.
He indicated that the university administration has great confidence in its scientists and researchers in developing an effective vaccine against the Coronavirus.
The university president stated that the institution will not skimp on the efforts of its scientists or the budgets it requires to find a scientific solution to confront the Coronavirus, pointing out that so far two research papers have been issued by Dr. Abdo Al-Faqi, associate professor in the Department of Biophysics at the Faculty of Science, on anti-reuse (HCV) and nucleotide inhibitors against the (COVID-19). This research was published in the International Life Sciences magazine.
Another research was on (predicting the location of the binding between the novelty of Corona spike and the cellular receptor GRP78); it was published in the International Journal of Infection.
The associate professor in the Department of Biophysics predicted that the location of the link between the spike protein of our new recurrence and the cellular receptor GRP78, which may represent one of the ways the virus enters the host cell by increasing the percentage of GRP78 protein that is linked to the elderly and owners chronic diseases and tumors.
This may be responsible for increasing the rate of infection and death rates and therefore we need to obtain a spike protein so that these results can be proven and applied in practice to produce an anti-correlation drug, and the same protein can be used to produce vaccines.
Cairo university president indicated that the second research entitled (HCV reuse and nucleotide inhibitors against the ( COVID-19), in which the researcher concluded to the construction of a polymerase protein model for the emerging the of novel Coronavirus which is necessary for the course of virus infection within the host cell.
The researcher also concluded that this conclusion was build on the similarity in the genetic sequence of the polymerase protein between the Coronavirus and SARS virus. Antiviral drugs were used to target the polymerization protein of the novel Coronavirus.
The research recommends the use of drugs such as Sofosburvir, Remdisivir, and Ribavirin to give results effectively against the novel Coronavirus. Those drugs could be applied to clinical trials.
Contributed by Ahmed Moamar
Follow the latest news on Google News
